WO1991008311A1 - METHODS OF COATING VIRAL ANTIGENS IN THE PRESENCE OF NONIONIC DETERGENTS AND ACIDIC pH ONTO A SOLID PHASE - Google Patents

METHODS OF COATING VIRAL ANTIGENS IN THE PRESENCE OF NONIONIC DETERGENTS AND ACIDIC pH ONTO A SOLID PHASE Download PDF

Info

Publication number
WO1991008311A1
WO1991008311A1 PCT/US1990/006922 US9006922W WO9108311A1 WO 1991008311 A1 WO1991008311 A1 WO 1991008311A1 US 9006922 W US9006922 W US 9006922W WO 9108311 A1 WO9108311 A1 WO 9108311A1
Authority
WO
WIPO (PCT)
Prior art keywords
solid phase
acidic
coating
viral antigens
onto
Prior art date
Application number
PCT/US1990/006922
Other languages
French (fr)
Inventor
Bryan Francis
Original Assignee
Baxter Diagnostics Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Diagnostics Inc. filed Critical Baxter Diagnostics Inc.
Publication of WO1991008311A1 publication Critical patent/WO1991008311A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses

Definitions

  • This invention relates to a process to coat viral antigens in the presence of nonionic detergent and acidic pH, onto a solid phase, to enhance the activity of bound viral antigens.
  • Antibodies are immobilized on solid phases, such as microtiter plates and latex beads, for use in research and diagnostic assays. Detection of monoclonal antibodies to membrane-associated proteins, however, presents a problem, since nonionic detergents used to
  • This invention relates to a method to increase the concentration of viral antigen on a solid phase by coating the solid phase with lu viral antigen in the presence of nonionic detergents, such as Triton X-l ⁇ U or NP4U, in acidic pH.
  • nonionic detergents such as Triton X-l ⁇ U or NP4U
  • Antigen was diluted into a coating buffer and added to lb particles.
  • the coating buffer was preferably comprised of 0.1 M acetate, pH b.O with 5* NP40, however, other nonionic detergents, such as Triton X-100, can be used. It was observed, however, that one nonionic detergent, Tween, did not result in a sufficiently high concentration of antigen to conduct an immunoassay.
  • 2U tion of detergent can range from .2% to 10 , with the optimum concentration from between about 1 and 10%. It was observed that pH can range from 4.U to 6.U, with the optimum pH at 5.0.
  • Buffer A was comprised of b 0.1 M acetate, at a pH 5.0.
  • Buffer B was comprised of 0.1 M acetate, 0.1 M NaCl, at a pH 5.0.
  • Buffer C was comprised of 0.1 M acetate, 0.1 M NaCl, 0.2% NP40, at a pH 5.0.
  • HIV negative serum was designated "617", positive was designated “618", and high positive serum was designated “R-J 1825”.
  • SDB sample dilution buffer
  • the dialyzed preparation was coated at 1/2 dilution with coating buffers A, B, and C on to 1 ml of 2.5% carboxylated paramagnetic particles (3.5 urn). Particles were incubated overnight at 2 Q 8 lb C. The particles were pelleted, the supernatent was discarded, and the particles were resuspended in 1% normal goat serum (NGS) in 0.1 M acetate, at a pH 5.0.
  • NGS normal goat serum
  • the coated particles were incubated for two hours at room temperature, then washed three times with 1 L isotonic buffered U saline (IBS).
  • IBS isotonic buffered U saline
  • the coating buffer "C” comprised of 0.1 M acetate, 0.1 M NAC1 , 30 and 0.2A NP40, and resulted in a greater concentration of viral antigens on the solid phase.
  • AIDS antigens coated in the presence of nonionic detergents and acidic pH resulted in viral coated particles witn enhanced activity over particles coated using other buffers.

Abstract

This invention relates to a process to enhance the activity of viral antigens that are bound to a solid phase. The viral antigens are coated to a solid phase in the presence of a nonionic detergeent, such as Triton X-100 or NP40, in a solution having an acidic pH.

Description

Methods of Coating Viral Antigens in the Presence of Nonionic Detergents and Acidic pH onto a Solid Phase
5 BACKGROUND OF THE INVENTION 1. Field of the Invention
This invention relates to a process to coat viral antigens in the presence of nonionic detergent and acidic pH, onto a solid phase, to enhance the activity of bound viral antigens.
1U 2. Description of the Prior Art
Antibodies are immobilized on solid phases, such as microtiter plates and latex beads, for use in research and diagnostic assays. Detection of monoclonal antibodies to membrane-associated proteins, however, presents a problem, since nonionic detergents used to
ID solubilize membrane antigens retard or prevent protein binding to latex microtiter wells. G. Urexler et al . , A Rapid and Simple Method for Efficient Coating of Microtiter Plates Using Low Amounts of Antigen in the Presence of Detergent, 95 J. Immuno. Metn. 117 (1986). Gardas et al., Coating of Proteins in the Presence of
2ϋ Detergents, 10b J. Immuno. Meth. 251 (1988). This problem nas been addressed in the past with a variety of solutions. One investigator suggested using glutoraldehyde to immobilize antigen in the presence of detergent. G. Evans, 73 J. Immuno. 427 (1984). Another investigator suggested the use of Bouin's fluid to increase the
2b binding of antigen -solubilize with a nonionic detergent. Notebooπ et al., 7b J. Immuno. Meth. 141 (1984). Still another investigator disclosed a process to increase the binding of antigen to a microtiter plate using beads to adsorb the residual nonionic detergent. See Drexler, supra. One author, however, suggested that iu proteins can oe effectively bound to latex surfaces provided that a detergent witn a hign critical micelle concentration (CMC), i.e. the concentration ot a detergent which allows the formation of micelles, is used. See Garαas, supra. This investigator tested the nonionic detergent, Triton X-100, among other detergents, at a concentration of .2 or .b% and a pH of 9.6. From this experiment, one skilled in the relevant art would conclude that this nonionic detergent, i.e. Triton X-100, inhibits binding at one of the lowest concentrations b and thus would appear to be a poor choice for use in an immunoassay.
SUMMARY OF THE INVENTION
This invention relates to a method to increase the concentration of viral antigen on a solid phase by coating the solid phase with lu viral antigen in the presence of nonionic detergents, such as Triton X-lύU or NP4U, in acidic pH.
DETAILED DESCRIPTION OF THE INVENTION
Antigen was diluted into a coating buffer and added to lb particles. The coating buffer was preferably comprised of 0.1 M acetate, pH b.O with 5* NP40, however, other nonionic detergents, such as Triton X-100, can be used. It was observed, however, that one nonionic detergent, Tween, did not result in a sufficiently high concentration of antigen to conduct an immunoassay. The concentra-
2U tion of detergent can range from .2% to 10 , with the optimum concentration from between about 1 and 10%. It was observed that pH can range from 4.U to 6.U, with the optimum pH at 5.0. Example 1 - Coating of HIV antigen onto magnetic microparticles using NP4D and acid pH.
2b 1 ml of 4 X 10**-* particles/ml of 3 - 4 micron carboxylated magnetic particles were pelleted and the supernatent was carefully removed and discarded. Tne particles were resuspended in 1 ml of 0.1 M acetate buffer, pH 5.0, containing b% NP40 and 250 ug/ml of HIV antigen. The particles were tumbled end over end at 5 - 6 rpm
3U overnignt at room temperature. The particles were pelleted and supernatent was discarded. The particles were resuspended in 1 ml oτ PBS, pelleted and tne supernatent was discarded. This was re- peated two times. The particles were resuspended in 1 ml of diluent (0.1M acetate, pH b.O, U.5M NAC1 , 1% NaN ) and stored at 2 - 8°. Example 2 - Comparison of coating conditions.
5 ml of solution containing HIV antigen, was dialyzed against three changes of four liters of 0.1 M acetate pH 5.0. Three different coating buffers were assessed: Buffer A was comprised of b 0.1 M acetate, at a pH 5.0. Buffer B was comprised of 0.1 M acetate, 0.1 M NaCl, at a pH 5.0. Buffer C was comprised of 0.1 M acetate, 0.1 M NaCl, 0.2% NP40, at a pH 5.0.
HIV negative serum was designated "617", positive was designated "618", and high positive serum was designated "R-J 1825". These 10 sera were diluted 1/100 in sample dilution buffer (SDB) (32% calf serum, 0.02M phosphate, pH 7.4, O.faM NAC1 , 1% NP40, and 0.1% NaN3).
The dialyzed preparation was coated at 1/2 dilution with coating buffers A, B, and C on to 1 ml of 2.5% carboxylated paramagnetic particles (3.5 urn). Particles were incubated overnight at 2 Q 8 lb C. The particles were pelleted, the supernatent was discarded, and the particles were resuspended in 1% normal goat serum (NGS) in 0.1 M acetate, at a pH 5.0.
The coated particles were incubated for two hours at room temperature, then washed three times with 1 L isotonic buffered U saline (IBS).
20ul of particles (1 X 107 parts/mL) were added to 50 ul of sample (1/lUO in SBD). This mixture was incubated for 30 minutes at 37°C. The solid phase was washed to remove unbound material. 50 ul of goat anti-human beta glactosidase labeled antibody was added to 5 the mixture. This mixture was then incubated for 15 minutes at 37°C. The mixture was washed to remove unbound antibody and 50 ul substrate (B-D-galactopyranoside) was added. The fluorescence was read at 2 and 14 minutes using a Pandex" FCA instrument. The results are reported below. D Tabl e 1
S D B 617 618 1825
Figure imgf000006_0001
10 Tabl e 2
S D B 617 618 1825
Buffer A 8 781.3 + 145.5 5449.7 (7.0) 19738 (25.3) Buffer B 7.5 970.7 +_ 130.6 5287.7 (5.4) 23484 (24.2) Buffer C 0 611.7 + 5y .5 5136.7 (8.4) 15434 (25.2) lb Cnannel Report : 400/450 Gai n Setti ng : 10 Read Time : 100 ms
Table 3
2U
Figure imgf000006_0002
25 Delta Read (Table 2 - Table 1)
Conclusions
The coating buffer "C" comprised of 0.1 M acetate, 0.1 M NAC1 , 30 and 0.2A NP40, and resulted in a greater concentration of viral antigens on the solid phase. AIDS antigens coated in the presence of nonionic detergents and acidic pH resulted in viral coated particles witn enhanced activity over particles coated using other buffers.

Claims

I Cl ai m:
1. An active solid phase coated with viral antigen made by the process comprising:
5 Coating a solid phase with viral antigen in an acidic suspension of a nonionic detergent, and a buffer.
2. The active solid phase of Claim 1 wherein the concentration of said detergent ranges from .2 to 10%.
3. The active solid phase of Claim 1 wherein said solid phase is a 10 paramagnetic microparticle.
4. The active solid phase of Claim 1 wherein said detergent is NP40 or Triton X-100. b. The active solid phase of Claim 1 wherein the pH of the suspension ranges from about 4.0 to 6.0. lb 6. Tne active solid phase of Claim 1 wherein the pH is about 5.0.
2U
b
3D
PCT/US1990/006922 1989-11-29 1990-11-28 METHODS OF COATING VIRAL ANTIGENS IN THE PRESENCE OF NONIONIC DETERGENTS AND ACIDIC pH ONTO A SOLID PHASE WO1991008311A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44363589A 1989-11-29 1989-11-29
US443,635 1989-11-29

Publications (1)

Publication Number Publication Date
WO1991008311A1 true WO1991008311A1 (en) 1991-06-13

Family

ID=23761588

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1990/006922 WO1991008311A1 (en) 1989-11-29 1990-11-28 METHODS OF COATING VIRAL ANTIGENS IN THE PRESENCE OF NONIONIC DETERGENTS AND ACIDIC pH ONTO A SOLID PHASE

Country Status (5)

Country Link
EP (1) EP0455807A4 (en)
JP (1) JPH04507003A (en)
AU (1) AU7160491A (en)
CA (1) CA2045682A1 (en)
WO (1) WO1991008311A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110596374A (en) * 2019-09-19 2019-12-20 潍坊市康华生物技术有限公司 Method for coupling magnetic particles and antigen

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870003A (en) * 1987-06-15 1989-09-26 Coulter Corporation Simultaneous enzyme immunoassay for detecting antigen and/or antibody in humans

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0136798A3 (en) * 1983-08-25 1986-02-19 Biotech Research Laboratories Inc. Titre plate and assay kit for detection of antibodies in human serum and their production and use
EP0316495A1 (en) * 1987-11-19 1989-05-24 Iaf Biochem International Inc. Synthetic peptides useful for the detection of aids-related antibodies in human sera
US5077198A (en) * 1988-04-14 1991-12-31 Eastman Kodak Company Diagnostic kit and method for rapid detection of antibodies

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870003A (en) * 1987-06-15 1989-09-26 Coulter Corporation Simultaneous enzyme immunoassay for detecting antigen and/or antibody in humans

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Journal of Immunological Methods, Volume 106 issued February 1988, GARDAS et al., "Coating of proteins to polystyrne ELISA plates in the presence of detergents", pages 251-255. See entire document. *
See also references of EP0455807A4 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110596374A (en) * 2019-09-19 2019-12-20 潍坊市康华生物技术有限公司 Method for coupling magnetic particles and antigen

Also Published As

Publication number Publication date
JPH04507003A (en) 1992-12-03
EP0455807A1 (en) 1991-11-13
CA2045682A1 (en) 1991-05-30
EP0455807A4 (en) 1992-07-08
AU7160491A (en) 1991-06-26

Similar Documents

Publication Publication Date Title
JPH02503950A (en) Simultaneous enzyme immunoassay for detecting human antigens and/or antibodies
US5141848A (en) Confirmatory immunoassay using microparticle separation
IE61407B1 (en) Enzyme immunoassay for detecting hiv antigens in hyman sera
JPH10197531A (en) Immunity dissociation to improve immunochemical measurement of inspection object substance
JPH1078435A (en) Rise of sensitivity in immunochemical measurement for material to be inspected
CA2097545C (en) Process for the immunochemical determination of an analyte
WO1991008311A1 (en) METHODS OF COATING VIRAL ANTIGENS IN THE PRESENCE OF NONIONIC DETERGENTS AND ACIDIC pH ONTO A SOLID PHASE
JPH05504400A (en) Antibody or antigen combination assays
EP0811165B1 (en) Detection of antibody production
US5534414A (en) Process for preparing conjugates consisting of a specific binding partner and a carbohydrate-containing protein
JPH07117541B2 (en) Immunological measurement method using magnetic particles
AU2007242647B2 (en) Method for assaying antigens
JP2596959B2 (en) Ligand assays
JP2004301646A (en) Nonspecific reaction absorbent for immunity inspection
CN108519481A (en) A method of improving core antibody magnetic microparticle chemiluminescence immune assay precision
NZ516587A (en) Assay
Menking et al. Antibodies in Air Assay: Application of ELISA to Aerosol Research.
Azze A new format ELISA for the detection of HBsAg
JP2001305137A (en) Method for immobilization and measurement of specific complex
JP4359416B2 (en) Measuring method of substance immobilized on microparticle solid phase
JPH11218534A (en) Nonspecific reaction absorbent and immunoassay using the absorbent
CN115754266A (en) Sample diluent applied to indirect immunoassay
JP2021143946A (en) Suppression method of nonspecific reaction
WO2000060353A1 (en) Composition for patient sample preparation
El-Aasser et al. Future Directions in the Latex Agglutination Assays Position Paper—# 2

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 2045682

Country of ref document: CA

Ref document number: 1991902536

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1991902536

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1991902536

Country of ref document: EP